Type 1 versus Type 2 Myocardial Infarction: Causation Implications in Missed MI Claims

In clinical negligence claims involving alleged missed myocardial infarction (MI), the distinction between Type 1 and Type 2 MI is frequently pivotal. This differentiation carries significant implications for breach of duty, causation, and quantum assessments. For solicitors and medico-legal practitioners, understanding the clinical frameworks and legal nuances is essential when instructing a cardiology expert witness or scrutinising a missed myocardial infarction claim.

Clinical Context: The Fourth Universal Definition of Myocardial Infarction

The Fourth Universal Definition of Myocardial Infarction, published by the European Society of Cardiology, American College of Cardiology, American Heart Association, and World Heart Federation, classifies MI into five types. For medico-legal purposes, Type 1 and Type 2 are the most relevant:

• Type 1 MI: Spontaneous MI related to atherosclerotic plaque rupture, ulceration, erosion, or dissection, resulting in intraluminal thrombus and reduced myocardial blood flow.
• Type 2 MI: MI secondary to an ischaemic imbalance, where a condition other than coronary artery disease contributes to an imbalance between myocardial oxygen supply and demand. Examples include severe anaemia, tachyarrhythmias, hypertension, or hypotension.

High-sensitivity troponin assays are central to diagnosing both types, but the clinical context and underlying mechanism differ substantially. NICE guidance (NG185) on acute coronary syndromes emphasises the importance of interpreting troponin results alongside the patient’s presentation, ECG findings, and risk stratification tools such as the HEART or GRACE scores. Failure to consider these factors may form the basis of an alleged breach in a missed myocardial infarction claim.

Legal Relevance: Breach, Causation, and the Bolam/Bolitho Test

The distinction between Type 1 and Type 2 MI is not merely academic; it directly influences the legal analysis of breach and causation.

Breach of Duty

Under the Bolam test, as refined by Bolitho, a clinician’s actions are measured against what a responsible body of medical opinion would consider acceptable. In a missed myocardial infarction claim, the question often arises: was the failure to diagnose or appropriately manage the MI a breach of duty?

For Type 1 MI, the standard of care is well-established. NICE guidance (NG185) sets clear pathways for the investigation and management of suspected acute coronary syndromes, including the use of high-sensitivity troponin testing at 0 and 1 or 3 hours, ECG interpretation, and risk stratification. Alleged deviations from these pathways, such as delayed troponin testing or misinterpretation of subtle ECG changes (e.g., posterior MI, de Winter T-waves, or Wellens syndrome), may support a claim of breach.

For Type 2 MI, the standard of care is less prescriptive. The underlying cause (e.g., sepsis, arrhythmia, or anaemia) often dictates the management approach. Expert opinion may address whether the clinician appropriately identified and addressed the precipitating factor, rather than focusing solely on coronary artery disease. For example, in a patient with Type 2 MI secondary to sepsis, the alleged breach may relate to delayed antibiotic administration or inadequate fluid resuscitation, rather than a failure to initiate antiplatelet therapy.

Causation

Causation in a missed myocardial infarction claim is assessed using the “but for” test, as established in Barnett v Chelsea and Kensington HMC [1969], and the material contribution test, as outlined in Bailey v Ministry of Defence [2008] and Williams v Bermuda Hospitals Board [2016]. The distinction between Type 1 and Type 2 MI is critical here.

In Type 1 MI, the natural history of atherosclerotic plaque rupture and thrombus formation is well-understood. Expert evidence may address whether earlier intervention (e.g., percutaneous coronary intervention or thrombolysis) would have altered the outcome. The timing of intervention is particularly relevant, as the “time is muscle” principle underscores the importance of early reperfusion. For example, in a claimant who suffered a large anterior MI, expert opinion may assess whether a delay in diagnosis and treatment resulted in a greater infarct size, reduced left ventricular function, or increased risk of arrhythmia.

In Type 2 MI, causation is often more complex. The ischaemic imbalance may be multifactorial, and the expert must assess whether the alleged breach (e.g., failure to treat the underlying cause) materially contributed to the MI or its consequences. For instance, in a patient with Type 2 MI secondary to uncontrolled hypertension, the expert may consider whether earlier antihypertensive treatment would have prevented the ischaemic event. The eggshell skull principle, as established in Smith v Leech Brain [1962], may also apply if the claimant had pre-existing vulnerabilities, such as left ventricular hypertrophy or coronary artery disease.

Common Pitfalls and Disputes in Missed MI Claims

Several recurring issues arise in missed myocardial infarction claims, often centring on the interpretation of clinical findings and the application of guidelines.

Troponin Interpretation

High-sensitivity troponin assays have improved the detection of myocardial injury, but their interpretation remains contentious. A troponin rise may indicate Type 1 MI, Type 2 MI, or non-ischaemic myocardial injury (e.g., myocarditis or takotsubo cardiomyopathy). Expert opinion may address whether the clinician appropriately considered the clinical context, including the patient’s symptoms, ECG findings, and risk factors. For example, a troponin rise in a patient with chest pain and dynamic ST-segment changes is more likely to represent Type 1 MI, whereas a troponin rise in a patient with sepsis and no chest pain may indicate Type 2 MI or non-ischaemic injury.

ECG Misinterpretation

Subtle ECG changes, such as posterior MI or de Winter T-waves, are frequently overlooked. Expert evidence may assess whether the clinician’s interpretation of the ECG met the standard of care. For example, in a claimant with posterior MI, the expert may consider whether the absence of reciprocal ST-segment depression in the anterior leads contributed to the missed diagnosis.

Risk Stratification

NICE guidance (NG185) recommends the use of risk stratification tools, such as the HEART or GRACE scores, to guide management. Alleged failures to apply these tools may form the basis of a breach of duty. Expert opinion may address whether the clinician’s decision-making aligned with responsible medical practice, even if it deviated from the guideline.

Discharge Decisions

Premature discharge is a frequent allegation in missed myocardial infarction claims. Expert evidence may assess whether the clinician appropriately considered the patient’s risk profile, including troponin results, ECG findings, and clinical stability. For example, in a claimant with a low-risk HEART score but rising troponin, the expert may consider whether discharge was reasonable or whether further observation was warranted.

The Role of the Cardiology Expert Witness

In a missed myocardial infarction claim, the cardiology expert witness plays a critical role in addressing breach, causation, and quantum. Under CPR Part 35, the expert’s duty is to the court, not to the instructing party. The expert must provide an independent, objective opinion based on the available evidence.

Breach of Duty Assessment

The expert may assess whether the clinician’s actions met the standard of care, considering the Bolam and Bolitho tests. This involves reviewing the clinical records, including troponin results, ECGs, and risk stratification scores, and comparing the management against applicable guidelines (e.g., NICE NG185). The expert must also consider whether the clinician appropriately tailored the management to the patient’s individual circumstances.

Causation Analysis

The expert’s causation analysis must address whether the alleged breach materially contributed to the claimant’s outcome. This may involve assessing the natural history of the MI, the timing of intervention, and the claimant’s pre-existing vulnerabilities. For example, in a Type 1 MI claim, the expert may consider whether earlier reperfusion would have preserved left ventricular function or reduced the risk of arrhythmia. In a Type 2 MI claim, the expert may assess whether earlier treatment of the underlying cause (e.g., sepsis or arrhythmia) would have prevented the ischaemic event.

Quantum Considerations

The expert may also address quantum issues, such as the claimant’s prognosis, life expectancy, and need for future care. This may involve reviewing the claimant’s echocardiogram results, functional capacity (e.g., NYHA class), and response to treatment. The expert must provide an objective assessment, avoiding overstatement or minimisation of the claimant’s condition.

Practical Guidance for Solicitors

For solicitors handling a missed myocardial infarction claim, early instruction of a cardiology expert witness is advisable. The following steps may strengthen the claim:

• Obtain Comprehensive Medical Records: Ensure all relevant records, including troponin results, ECGs, and risk stratification scores, are obtained and reviewed by the expert.
• Identify the Type of MI: Clarify whether the MI was Type 1 or Type 2, as this will influence the breach and causation analysis.
• Assess Compliance with Guidelines: Review whether the clinician’s management aligned with NICE guidance (NG185) or other applicable frameworks.
• Consider Subspecialty Input: In complex cases, such as those involving inherited arrhythmia syndromes or structural heart disease, consider instructing a subspecialist expert (e.g., electrophysiologist or heart failure specialist).
• Prepare for Joint Expert Discussions: Under CPR Part 35, experts may be required to produce a joint statement. Ensure the expert is prepared to engage in constructive dialogue with the opposing expert.

In fatal cases, the coronial process may also provide valuable evidence. A Prevention of Future Deaths report, issued under regulation 28 of the Coroners (Investigations) Regulations 2013, may highlight systemic issues relevant to the claim.

Conclusion

The distinction between Type 1 and Type 2 MI is fundamental in a missed myocardial infarction claim. While Type 1 MI involves a clear atherosclerotic mechanism, Type 2 MI is multifactorial and often secondary to an underlying condition. This distinction influences the legal analysis of breach, causation, and quantum, making it essential for solicitors and medico-legal practitioners to understand the clinical and legal frameworks.

Specialist cardiology medico-legal assessment from an experienced consultant cardiologist expert witness can be pivotal in cases of this nature. Early instruction, thorough record review, and clear communication with the expert will ensure that the claim is robustly supported by clinical and legal evidence.